Absolutely......The market is so huge that multiple players have enough room to make some decent returns.....
Even if Merck is first to market (potentially), this is a great bet.....
Look at MS markets...multiple players enter with similar clinical benefit but still makes good money...
Ann: Investor Roadshow Presentation, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $18.03M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $28.89K | 289.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73984 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 127592 | 3 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |